Chemically modified peanut extract shows increased safety while maintaining immunogenicity.
Hanneke P M van der KleijHans J M WarmenhovenRonald van ReeSerge A VersteegRaymond H H PietersStephen C DreskinAndré C KnulstEls van HoffenDirk Jan E OpsteltenStef J KoppelmanJoost J SmitPublished in: Allergy (2018)
In our studies, an Al(OH)3 adsorbed MPE showed reduced allergenicity compared to unmodified PE, while the efficacy of immunotherapy is maintained. The preclinical data presented in this study supports further development of modified peanut allergens for IT.